These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 36069598)

  • 1. A Closer Look at the Laboratory Impact of Utilizing ePlex Blood Culture Identification Panels: a Workflow Analysis Using Rapid Molecular Detection for Positive Blood Cultures.
    Tansarli GS; Chapin KC
    Microbiol Spectr; 2022 Oct; 10(5):e0179622. PubMed ID: 36069598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Performance of the Novel GenMark Dx ePlex Blood Culture ID Gram-Positive Panel.
    Carroll KC; Reid JL; Thornberg A; Whitfield NN; Trainor D; Lewis S; Wakefield T; Davis TE; Church KG; Samuel L; Mills R; Jim P; Young S; Nolte FS
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31996444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of Broad-Panel PCR-Based Bacterial Identification for Blood Cultures in a Pediatric Oncology Population.
    Garner CD; Brazelton de Cardenas J; Suganda S; Hayden RT
    Microbiol Spectr; 2021 Sep; 9(1):e0022121. PubMed ID: 34232100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the ePlex Blood Culture Identification Panels for Detection of Pathogens in Bloodstream Infections.
    Huang TD; Melnik E; Bogaerts P; Evrard S; Glupczynski Y
    J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30487304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical impact of implementing GenMark ePlex blood culture panels for around-the-clock blood culture identification; a prospective observational study.
    Krifors A; Rådberg G; Golbob S; Omar Z; Svensson C; Heimer D; Carlander C
    Infect Dis (Lond); 2020 Oct; 52(10):705-712. PubMed ID: 32522111
    [No Abstract]   [Full Text] [Related]  

  • 6. A Multicenter Clinical Study To Demonstrate the Diagnostic Accuracy of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel.
    Wolk DM; Young S; Whitfield NN; Reid JL; Thornberg A; Carroll KC; Buchan BW; Davis TE; Salimnia H
    J Clin Microbiol; 2021 Aug; 59(9):e0248420. PubMed ID: 34232066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Test Performance and Potential Clinical Utility of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel.
    McCarty TP; Cumagun P; Meeder J; Moates D; Edwards WS; Hutchinson J; Lee RA; Leal SM
    Microbiol Spectr; 2023 Feb; 11(1):e0409222. PubMed ID: 36688641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Microbiological Performance and the Potential Clinical Impact of the ePlex
    Bryant S; Almahmoud I; Pierre I; Bardet J; Touati S; Maubon D; Cornet M; Richarme C; Maurin M; Pavese P; Caspar Y
    Front Cell Infect Microbiol; 2020; 10():594951. PubMed ID: 33324578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT).
    Claeys KC; Hopkins TL; Schlaffer K; Hitchcock S; Jiang Y; Evans S; Johnson JK; Leekha S
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0044121. PubMed ID: 34228533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical impact of early detection of ESBL-producing Enterobacterales with PCR-based blood culture assays.
    Chang KM; Haghamad A; Saunders-Hao P; Shaffer A; Mirsaidi N; Zimilover A; Epstein M; Jain S; Streva V; Juretschko S; Demissie S; Gautam-Goyal P
    Am J Infect Control; 2024 Jan; 52(1):73-80. PubMed ID: 37544512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical performance and potential clinical utility of the GenMark Dx ePlex® blood culture identification gram-positive panel.
    McCarty TP; White CM; Meeder J; Moates D; Pierce HM; Edwards WS; Hutchinson J; Lee RA; Leal SM
    Diagn Microbiol Infect Dis; 2022 Nov; 104(3):115762. PubMed ID: 35988351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of two rapid molecular test systems to establish an algorithm for fast identification of bacterial pathogens from positive blood cultures.
    Oberhettinger P; Zieger J; Autenrieth I; Marschal M; Peter S
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1147-1157. PubMed ID: 32020397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of ePlex® blood culture identification panels in clinical isolates and characterization of antimicrobial stewardship opportunities.
    Thomas JK; Clark J; Arora V; Burgess DS; Burgess DR; Mynatt RP; VanHoose JD; Wallace KL; Cotner SE
    Diagn Microbiol Infect Dis; 2024 Jul; 109(3):116269. PubMed ID: 38692201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter Evaluation of the FilmArray Blood Culture Identification 2 Panel for Pathogen Detection in Bloodstream Infections.
    Caméléna F; Péan de Ponfilly G; Pailhoriès H; Bonzon L; Alanio A; Poncin T; Lafaurie M; Dépret F; Cambau E; Godreuil S; Chenouard R; Le Monnier A; Jacquier H; Berçot B
    Microbiol Spectr; 2023 Feb; 11(1):e0254722. PubMed ID: 36519852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter Evaluation of a PCR-Based Digital Microfluidics and Electrochemical Detection System for the Rapid Identification of 15 Fungal Pathogens Directly from Positive Blood Cultures.
    Zhang SX; Carroll KC; Lewis S; Totten M; Mead P; Samuel L; Steed LL; Nolte FS; Thornberg A; Reid JL; Whitfield NN; Babady NE
    J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32075904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of novel rapid diagnostic of blood culture identification and antimicrobial susceptibility testing by Accelerate Pheno system and BioFire FilmArray Blood Culture Identification and BioFire FilmArray Blood Culture Identification 2 panels.
    Sze DTT; Lau CCY; Chan TM; Ma ESK; Tang BSF
    BMC Microbiol; 2021 Dec; 21(1):350. PubMed ID: 34922463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Impact of the Expanded BioFire Blood Culture Identification 2 Panel in a U.S. Children's Hospital.
    Graff KE; Palmer C; Anarestani T; Velasquez D; Hamilton S; Pretty K; Parker S; Dominguez SR
    Microbiol Spectr; 2021 Sep; 9(1):e0042921. PubMed ID: 34431685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of peptide nucleic acid fluorescence in situ hybridization assays with culture-based matrix-assisted laser desorption/ionization-time of flight mass spectrometry for the identification of bacteria and yeasts from blood cultures and cerebrospinal fluid cultures.
    Calderaro A; Martinelli M; Motta F; Larini S; Arcangeletti MC; Medici MC; Chezzi C; De Conto F
    Clin Microbiol Infect; 2014 Aug; 20(8):O468-75. PubMed ID: 24304149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Evaluation of the Accelerate Pheno System for Susceptibility Testing of Gram-Negative Bacteria Isolated from Blood Cultures.
    Patel YA; Kirn TJ; Weinstein MP; Uprety P
    Microbiol Spectr; 2021 Dec; 9(3):e0183621. PubMed ID: 34937177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Accelerate Pheno System for Fast Identification and Antimicrobial Susceptibility Testing from Positive Blood Cultures in Bloodstream Infections Caused by Gram-Negative Pathogens.
    Marschal M; Bachmaier J; Autenrieth I; Oberhettinger P; Willmann M; Peter S
    J Clin Microbiol; 2017 Jul; 55(7):2116-2126. PubMed ID: 28446572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.